Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.52 |
| ▸ | NTSR2 | O95665 | 8/20 | 0.52 |
| ▸ | NTSR1 | P30989 | 7/20 | 0.52 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29380576 | 0.95 | OPRM1 (0.59) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL29379358 | 0.94 | OPRD1 (0.52) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL30116347 | 0.94 | OPRD1 (0.57) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL29380132 | 0.94 | OPRD1 (0.52) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL31683331 | 0.94 | OPRD1 (0.52) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL29380423 | 0.92 | OPRD1 (0.55) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL29765222 | 0.92 | OPRM1 (0.62) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL29392625 | 0.91 | OPRD1 (0.54) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL30629451 | 0.91 | OPRD1 (0.59) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL30631183 | 0.91 | OPRD1 (0.60) | OPRM1NTSR2NTSR1SORT1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022164222-A2 | PHARMACEUTICAL COMPOSITION COMPRISING GIP DERIVATIVE OR LONG-ACTING CONJUGATE THEREOF FOR PREVENTING OR TREATING PULMONARY DISEASE | 한미약품 주식회사 | 2022-08-04 | — | — | WO | disclosed |
| WO-2022080986-A1 | GLP-1/GIP DUAL AGONIST, LONG-ACTING CONJUGATE THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 한미약품 주식회사 | 2022-04-21 | — | — | WO | disclosed |
| WO-2022080985-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LUPUS-RELATED DISEASES COMPRISING GIP DERIVATIVE OR LONG-ACTING CONJUGATE THEREOF | 한미약품 주식회사 | 2022-04-21 | — | — | WO | disclosed |
| WO-2022080984-A1 | GIP DERIVATIVE, LONG-ACTING CONJUGATE THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 한미약품 주식회사 | 2022-04-21 | — | — | WO | disclosed |
| WO-2022080989-A1 | PHARMACEUTICAL COMPOSITION COMPRISING GLUCAGON/GLP-1/GIP TRIPLE AGONIST OR LONG-ACTING CONJUGATE THEREOF FOR PREVENTING OR TREATING LUPUS-RELATED DISEASES | 한미약품 주식회사 | 2022-04-21 | — | — | WO | disclosed |
| WO-2022080987-A1 | PHARMACEUTICAL COMPOSITION COMPRISING GLUCAGON/GLP-1/GIP TRIPLE AGONIST OR LONG-ACTING CONJUGATE THEREOF FOR PREVENTING OR TREATING VASCULITIS | 한미약품 주식회사 | 2022-04-21 | — | — | WO | disclosed |